TRIFLUPROMAZINE
| SMILES | CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 |
| InChIKey | XSCGXQMFQXDFCW-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 3 |
| Hydrogen bond donors | 0 |
| Rotatable bonds | 4 |
| Molecular weight (Da) | 352.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.4 | 8.4 | 8.4 | PDSP Ki database |
| D2 | DRD2 | Human | Dopamine | A | pKi | 8.55 | 8.55 | 8.55 | PDSP Ki database |
| H1 | HRH1 | Rat | Histamine | A | pKi | 7.28 | 7.28 | 7.28 | PDSP Ki database |
| D1 | DRD1 | Bovine | Dopamine | A | pKi | 6.28 | 6.28 | 6.28 | PDSP Ki database |
| D2 | DRD2 | Bovine | Dopamine | A | pKi | 8.68 | 8.68 | 8.68 | PDSP Ki database |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.08 | 8.08 | 8.08 | Drug Central |
| D2 | DRD2 | Human | Dopamine | A | pKi | 8.07 | 8.07 | 8.07 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| M1 | ACM1 | Rat | Acetylcholine (muscarinic) | A | Potency | 6.0 | 6.4 | 6.8 | ChEMBL |
| NPS | NPSR1 | Human | Neuropeptide S | A | Potency | 4.9 | 4.9 | 4.9 | ChEMBL |
| TSH | TSHR | Human | Glycoprotein hormone | A | Potency | 4.4 | 4.4 | 4.4 | ChEMBL |